The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer

• Takuya Shiota ,

  Contributed equally to this work with: Takuya Shiota, Yuko Miyasato, Koji Ohnishi

  Affiliation Department of Cell Pathology Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯
• Yuko Miyasato ,

  Contributed equally to this work with: Takuya Shiota, Yuko Miyasato, Koji Ohnishi

  Affiliation Department of Cell Pathology Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯
• Koji Ohnishi ,

  Contributed equally to this work with: Takuya Shiota, Yuko Miyasato, Koji Ohnishi

  Affiliation Department of Cell Pathology Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯
• Mutsuko Yamamoto-Ibusuki,

  Affiliation Department of Molecular-Targeting Therapy for Breast Cancer, Kumamoto University Hospital, Kumamoto, Japan

  ⨯
• Yutaka Yamamoto,

  Affiliation Department of Breast and Endocrine Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan

  ⨯
• Hirotaka Iwase,

  Affiliation Department of Breast and Endocrine Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan

  ⨯
• Motohiro Takeya,

  Affiliation Department of Cell Pathology Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯
• Yoshihiro Komohara

  * E-mail: ycomo@kumamoto-u.ac.jp

  Affiliation Department of Cell Pathology Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan

  ⨯